John Bernard Buse - the UNC Department of Medicine
John Bernard Buse - the UNC Department of Medicine
John Bernard Buse - the UNC Department of Medicine
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Buse</strong>, Curriculum Vitae p. 14 <strong>of</strong> 29 Updated: August 2008<br />
30. American Diabetes Association. Consensus statement: <strong>the</strong> prevention or delay <strong>of</strong> type 2<br />
diabetes. Diabetes Care 25:742-749, 2002.<br />
31. <strong>Buse</strong> JB, Weyer C, Maggs DG. Amylin replacement with pramlintide in type 1 and type 2<br />
diabetes: A physiological approach to overcome barriers with insulin <strong>the</strong>rapy. Clinical<br />
Diabetes 20:137-144, 2002.<br />
32. <strong>Buse</strong> JB. Metabolic side effects <strong>of</strong> antipsychotics: focus on hyperglycemia and diabetes.<br />
Journal <strong>of</strong> Clinical Psychiatry 63(supplement 4): 37-41, 2002.<br />
33. <strong>Buse</strong>, JB. Diabetes tactics: Aggressive treatment <strong>of</strong> type 2 diabetes. Current Practice (The<br />
<strong>of</strong>ficial publication <strong>of</strong> <strong>the</strong> Council for <strong>the</strong> Advancement <strong>of</strong> Diabetes Research and Education)<br />
1(2):4-6, 2002.<br />
34. <strong>Buse</strong> JB. Insulin analogues. Current Opinion in Endocrinology & Diabetes 8:95-100, 2001.<br />
35. American Diabetes Association. Consensus statement: postprandial blood glucose. Diabetes<br />
Care 24:775-778, 2001.<br />
36. <strong>Buse</strong> JB. Progressive use <strong>of</strong> medical <strong>the</strong>rapies in type 2 diabetes. Diabetes Spectrum 13(4):<br />
211-220, 2000.<br />
37. <strong>Buse</strong> JB. Combining insulin and oral agents. American Journal <strong>of</strong> <strong>Medicine</strong> 108<br />
(Supplement 6a): 23-32, 2000.<br />
38. <strong>Buse</strong>, JB. Thiazolidinediones in <strong>the</strong> treatment <strong>of</strong> type 2 diabetes: a clinician’s perspective.<br />
American Journal <strong>of</strong> Managed Care 6(suppl 13):s710-7, 2000.<br />
39. <strong>Buse</strong>, JB. Pioglitazone in <strong>the</strong> treatment <strong>of</strong> type 2 diabetes mellitus: U.S. clinical experience.<br />
Experimental and Clinical Endocrinology & Diabetes (suppl 2) 108: 250-255, 2000.<br />
40. <strong>Buse</strong>, JB. The use <strong>of</strong> insulin alone and in combination with oral agents in type 2 diabetes.<br />
Primary Care Clinics in Office Practice 26: 931-50, 1999.<br />
41. American Diabetes Association. Consensus development conference on diabetic foot wound<br />
care. Simultaneously published Diabetes Care 22:1354-60, 1999 and Journal <strong>of</strong> <strong>the</strong><br />
American Podiatric Medical Association 89:475-483, 1999.<br />
42. <strong>Buse</strong> JB. Overview <strong>of</strong> current <strong>the</strong>rapeutic options in type 2 diabetes. Rationale for<br />
combining oral agents with insulin <strong>the</strong>rapy. Diabetes Care 22(suppl. 3): c65-70, 1999.<br />
43. <strong>Buse</strong>, JB. Management <strong>of</strong> glycemia in type 2 diabetes. Clinical Cornerstone. 1(3):39-57,<br />
1998.<br />
44. <strong>Buse</strong> JB and Hroscikoski M. The case for a role <strong>of</strong> postprandial glucose monitoring in<br />
diabetes management. Journal <strong>of</strong> Family Practice 47(suppl.):s29-s36, 1998.<br />
45. Sobel R, Meyer G, <strong>Buse</strong> JB. Brittle diabetes lessons for intensive insulin management.<br />
Practical Diabetology 13:12-22, 1994.<br />
46. Bell GI, Kayano T, <strong>Buse</strong> JB, Burant CF, Takeda J, Lin D, Fukumoto H, Seino S. Molecular<br />
biology <strong>of</strong> mammalian glucose transporters. Diabetes Care 13:198-208, 1990.<br />
47. <strong>Buse</strong> JB and Eisenbarth GS. Autoimmune endocrine disease. Vitamins and Hormones<br />
42:253-314, 1985.<br />
48. <strong>Buse</strong> JB and Eisenbarth GS. Monoclonal antibodies in endocrine immunodiagnosis.<br />
Clinical Chemistry News 9:19-21, 1982.<br />
49. <strong>Buse</strong> JB, Rowley RH, Eisenbarth GS. Disordered cellular immunity in type I diabetes <strong>of</strong><br />
man and <strong>the</strong> BB rat. Survey <strong>of</strong> Immunological Research 1:339-51, 1982.<br />
Editorials and Letters:<br />
1. <strong>Buse</strong> JB. Can we become victims <strong>of</strong> our own success? Diabetes Care 32:2140-1, 2009.
Change language